Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 9/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 1.00 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | CASP7 | P55210 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | FTO | Q9C0B1 | 2/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 2/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diacerein SCHEMBL29944894 | 1.00 | TTR (1.00) | TTRALDH1A1KDM4EHPGDMEN1 | |
| Diacerein SCHEMBL5051685 | 1.00 | TTR (1.00) | TTRALDH1A1KDM4EHPGDMEN1 | |
| Diacerein SCHEMBL29423907 | 1.00 | TTR (1.00) | TTRALDH1A1KDM4EHPGDMEN1 | |
| Diacerein SCHEMBL7438555 | 0.99 | TTR (0.97) | TTRALDH1A1KDM4EHPGDMEN1 | |
| Diacerein SCHEMBL5078956 | 0.99 | TTR (0.97) | TTRALDH1A1KDM4EHPGDMEN1 | |
| Diacerein SCHEMBL787907 | 0.99 | TTR (0.97) | TTRALDH1A1KDM4EHPGDMEN1 | |
| Diacerein SCHEMBL2326532 | 0.93 | TTR (0.86) | TTRALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL23655432 | 0.92 | TTR (0.84) | TTRALDH1A1KDM4EHPGDMEN1 | |
| Diacerein SCHEMBL5712120 | 0.92 | MEN1 (0.84) | TTRALDH1A1KDM4EHPGDMEN1 | |
| SCHEMBL16549421 | 0.90 | TTR (0.82) | TTRALDH1A1KDM4EHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6187 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118184604-B | Rhein-piperazine-sulfonamide hybrid, and preparation method and application thereof | 宁夏大学 | 2026-05-19 | — | — | CN | claimed |
| US-20260092050-A1 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | RAPT THERAPEUTICS INC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4680203-A1 | COMPOSITIONS FOR SUSTAINED RELEASE OF POORLY SOLUBLE ACTIVE INGREDIENTS | Prolevi Bio AB (SE) | 2026-01-21 | — | — | EP | claimed |
| EP-3699174-B1 | COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME | ILAB (KR) | 2025-11-12 | — | — | EP | claimed |
| EP-4640714-A2 | METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST | PML Screening, LLC (US) | 2025-10-29 | — | — | EP | claimed |
| EP-4636687-A1 | METHOD AND DEVICE FOR INSPECTING 3-DIMENSIONAL OBJECTS | ISRA VISION GMBH (DE) | 2025-10-22 | — | — | EP | claimed |
| EP-3713918-B1 | SULFASALAZINE SALTS, PRODUCTION PROCESSES AND USES | MEDAC GES FUER KLINISCHE SPEZIALPRAEPARATE MBH (DE) | 2025-07-23 | — | — | EP | claimed |
| WO-2025137471-A1 | DECELLULARIZED PLACENTA EXTRACELLULAR MATRIX AND USES THEREOF | CELULARITY INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250177565-A1 | METHODS AND MATERIALS FOR INHIBITING/PREVENTING THE TRAFFICKING OF MONOCYTES TO THE CENTRAL NERVOUS SYSTEM | DARTMOUTH COLLEGE (US) | 2025-06-05 | — | — | US | claimed |
| US-20250122208-A1 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | RAPT THERAPEUTICS, INC. | 2025-04-17 | — | — | US | claimed |
| WO-1992013864-A1 | ACYLAMINO-ALKYLIDEN-HYDROXY-BISPHOSPHONIC ACIDS USEFUL IN THE THERAPY OF OSTEOARTICULAR DISEASES | ISTITUTO GENTILI S.P.A. (IT) | 1992-08-20 | — | — | WO | claimed |
| EP-0264989-B1 | GALENIC FORMULATIONS FOR ORAL USE OF RHEIN DERIVATIVES WITH DELAYED RELEASE FOR THERAPEUTICAL USE | PROTER S.p.A. (IT) | 1991-12-18 | — | — | EP | claimed |
| EP-0243968-B1 | DIACETYLRHEIN POTASSIUM SALT AND ITS THERAPEUTICAL USE IN THE TREATMENT OF ARTHRITIS | PROTER S.p.A. (IT) | 1991-08-21 | — | — | EP | claimed |
| US-4950687-A | Diacetylrhein salts and their therapeutical use in the treatment of arthrosis | PROTER S.P.A. (IT) | 1990-08-21 | — | — | US | claimed |
| EP-0371431-A2 | Supported drugs with increased dissolution rate, and a process for their preparation | VECTORPHARMA INTERNATIONAL S.P.A. (IT) | 1990-06-06 | — | — | EP | claimed |
| EP-0364944-A1 | Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate | VECTORPHARMA INTERNATIONAL S.P.A. (IT) | 1990-04-25 | — | — | EP | claimed |
| US-4861599-A | Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use | PROTER S.P.A. (IT) | 1989-08-29 | — | — | US | claimed |
| EP-0264989-A1 | Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use | PROTER S.p.A. (IT) | 1988-04-27 | — | — | EP | claimed |
| EP-0243968-A2 | Diacetylrhein potassium salt and its therapeutical use in the treatment of arthritis | PROTER S.p.A. (IT) | 1987-11-04 | — | — | EP | claimed |
| US-4244968-A | HYDROXY- AND AMINO-ANTHRAQUINONES | PROTER S.P.A. (IT) | 1981-01-13 | — | — | US | claimed |